Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Patients With Intermittent Claudication Injected With ALDH Bright Cells

ClinicalTrials.gov ID: NCT01774097

Public ClinicalTrials.gov record NCT01774097. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 10:34 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Clinical and MR Imaging Assessments in Patients With Intermittent Claudication Following Injection of Bone Marrow Derived ALDH Bright Cells

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to find out if aldehyde dehydrogenase bright (ALDHbr) cells taken from a patient's bone marrow can be placed safely, via intramuscular injections, into their affected calf and lower thigh muscles and improve blood flow and/or peak walking time in patients experiencing pain associated with blocked blood vessels in the leg.

Study identification

NCT ID
NCT01774097
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
82 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2013 (Actual)
Primary completion
Aug 2016 (Actual)
Completion
Mar 2017 (Actual)
Last update posted
Apr 21, 2017

2013 – 2017

United States locations

U.S. sites
9
U.S. states
6
U.S. cities
8
Facility City State ZIP Site status
Stanford University School of Medicine (Falk Cardiovascular Research Center) Stanford California 94305 —
University of Florida-Department of Medicine Gainesville Florida 32610 —
University of Miami-Interdisciplinary Stem Cell Institute Miami Florida 33101 —
Orlando Health Inc. Orlando Florida 32806 —
Indiana Center for Vascular Biology and Medicine Indianapolis Indiana 46202 —
University of Louisville Louisville Kentucky 40202 —
Minneapolis Heart Institute Foundation Minneapolis Minnesota 55407 —
Clinical and Translational Science Institute at University of Minnesota Minneapolis Minnesota 55455 —
Texas Heart Institute Houston Texas 77030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01774097, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 21, 2017 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01774097 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →